Palace Hotel, San Fransisco, CA
May 01, 2012 - May 02, 2012
Jon Norris to lead keynote panel on Venture Capital at Allicense Conference
Venture Capital: Stepping Up or Stepping Out?
Overall equity financing for biopharma was up in 2011, but venture investing was down. This group of leading venture capitalists will discuss the state of private venture investing in biopharma and debate what can be expected in the next year.
- Session Chair: Jonathan Norris, Managing Director, Silicon Valley Bank
- Chris Ehrlich, General Partner, InterWest Partners
- Michael Grey, Venture Partner, Pappas Ventures
- Patrick Heron, General Partner, Frazier Healthcare,Biopharma Venture Team
Learn More and Register
E-mail This
The following excerpt will be included in your message.
The Deloitte Recap16th Annual Allicense MeetingMay 01, 2012 - May 02, 2012 Palace Hotel, San Fransisco, CAJon Norris to lead keynote panel on Venture Capital at Allicense Conference
Venture Capital: Stepping Up or Stepping Out?
Overall equity financing for biopharma was up in 2011, but venture investing was down. This group of leading venture capitalists will discuss the state of private venture investing in biopharma and debate what can be expected in the next year.
- Session Chair: Jonathan Norris, Managing Director, Silicon Valley Bank
- Chris Ehrlich, General Partner, InterWest Partners
- Michael Grey, Venture Partner, Pappas Ventures
- Patrick Heron, General Partner, Frazier Healthcare,Biopharma Venture Team
Learn More and Register